Skip to main content
. 2017 May 18;8(43):73817–73825. doi: 10.18632/oncotarget.17982

Figure 3.

Figure 3

(A) qRT-PCR showing expression level of CCL19 mRNA in cervical cancer-derived cell lines; (B) qRT-PCR showing the expression of CCL19 mRNA in ME-180/si cells was significantly decreased compared with control cells; (C) qRT-PCR showing the expression of CCL19 mRNA in Hela/si cells was significantly decreased compared with control cells; *P < 0.05, **P < 0.01.